Denise Bronner on Muck Rack

Denise Bronner

(She/Her)
Irvine
As seen in: Clinical Leader, Life Science Leader
Covers:  healthcare, pharma, entrepreneurship, clinical trials, leadership, DEI, caregiver

Get in touch with Denise

Contact Denise, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Denise Bronner’s Biography

Read Full Bio →

Denise N. Bronner, Ph.D., is the founder and CEO of Empactful Ventures, a boutique advisory firm operating at the intersection of pharma commercial strategy, healthtech commercialization, and patient and caregiver advocacy. She serves as Entrepreneur-in-Residence at Duke University's I-Cubed Innovation Center, on the board of WAI (We Are ILL), a chronic illness advocacy organization, and is a member of the Clinical Leader editorial board. She is also a caregiver for her father, who has navigate…

Denise Bronner’s Journalist Portfolio

See all →
Caregivers: The Missing Line Item In Trial Budgets

Caregivers: The Missing Line Item In Trial Budgets

More than 60 million Americans are caregivers, holding up a system and clinical research enterprise, yet they…

View article →
The Cost Of Transactional Thinking In Clinical Research

The Cost Of Transactional Thinking In Clinical Research

Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apa…

View article →
The U.S. Trial Advantage Is Eroding

The U.S. Trial Advantage Is Eroding

Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, econom…

View article →
How Government Shutdowns Set Back Clinical Trials

How Government Shutdowns Set Back Clinical Trials

When the federal government shuts down, clinical research suffers. Empactful Ventures Denise N. Bronner, Ph.D…

View article →
FDA Pharma Advertising Crackdown Reshapes Clinical Research, Too

FDA Pharma Advertising Crackdown Reshapes Clinical Research, Too

Empactul Ventures Denise N. Bronner, Ph.D., explores how the FDAs crackdown on pharmaceutical advertising mig…

View article →
How Digital Twins Are Rewriting Clinical Trials

How Digital Twins Are Rewriting Clinical Trials

While the benefits of digital twins to accelerate clinical trials are undeniable, many questions about their …

View article →

Articles

06.11.26 -- Why Contracts Need To Catch Up To AI Appears In Clinical Trials

|
By Katherine Leibowitz, Leibowitz Law, Denise Bronner
| Clinical Leader Verified
The Pulse: Global R&D Insights in Pharmaceuticals Uncertainty is shaping every major decision in drug development. Discover what 150 global biotech and pharma leaders say about navigating cost, complexity, regulation, artificial intelligence, and partnerships in 2026.
Open in Who Shared Issue with article?

The FDA Is Rudderless And Clinical Trials Are Left Adrift

|
By Denise Bronner, Empactful Ventures
| Clinical Leader Verified
By Denise N. Bronner, Ph.D., fractional chief strategist, Empactful Ventures Leadership vacuums are expensive. They can impact internal morale and external optics, as well as actual dollars, delayed timelines, and decisions that never get made because nobody with authority will make them. In pharma, when a program loses its executive champion, it stalls, budgets freeze, and teams go into a holding pattern. Now imagine that happening at the FDA.
Open in Who Shared Issue with article?
See all 2 articles

Interview

See all →

What was your first job as a journalist?

My first article that I penned was with Clinical Leader 2 years ago. They gave me the opportunity as a freelancer to pen my thoughts on the clinical trial landscape. To date I have published 12 articles with them.

Have you ever used a typewriter?

A long time ago and sometimes I miss it

How is social media changing news?

Social media didn't just change where we get news. It changed the speed and is killing accuracy. Many influencers have the reach without rigor. And in health, that gap has real consequences for patients regarding clinical decisions and for how the public understands science. What's missing is credible SME voices like clinicians, researchers, founders. The people who actually understand the work. They are largely absent from the platforms shaping public perception and that needs to change.
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified